MB Daly

MB Daly's indexed work centers on genetic counseling and risk communication for hereditary breast and ovarian cancer, particularly regarding _BRCA1/BRCA2_ mutations. Her most-cited publication, a 2010 last-authored study in _Clinical Genetics_ (44 citations), examined genetic counselor opinions and experiences with telephone communication of BRCA1/2 test results, providing early evidence on telemedicine's feasibility in cancer genetic counseling. A related 2007 validation study focused on the lambda model for predicting BRCA mutation carrier status in North American Ashkenazi Jewish women, adding to the literature on population-specific risk assessment. Beyond this core work, Daly contributed to a 2023 epidemiological investigation of adolescent physical activity and breast cancer risk in young women using the ProF-SC study cohort, and a 2020 case-only analysis of genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. Her publicly indexed outputs, spanning 2007–2023, suggest a focus on translating genetic risk information into clinical practice, though the portfolio is limited in breadth and citation impact.